Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedTaiwan location entry updated from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333. This clarifies the city designation in the study's locations list while keeping the same postal code, ensuring accurate site identification for potential participants.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the study record.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision: v3.4.3 was added as the latest update and Revision: v3.4.2 was removed. No changes to study content or data.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision: v3.4.2 is now displayed and the older government funding status notice (v3.4.1) has been removed. This is a minor administrative update that does not change study content, eligibility criteria, or results.SummaryDifference0.2%

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.